The Application of Propensity Score Analysis to Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Lilly Yue, Ph.D.* CDRH, FDA, Rockville.
V.: 9/7/2007 AC Submit1 Statistical Review of the Observational Studies of Aprotinin Safety Part I: Methods, Mangano and Karkouti Studies CRDAC and DSaRM.
Propensity Scores October 2014 Alexander M. Walker MD, DrPH Extensive parts of this presentation incorporate the work of John D. Seeger, PharmD, DrPH.
